News Archive

Personal loss inspired a Hollings researcher to apply breast cancer findings toward a potential new osteosarcoma treatment.

For patients running out of treatment options, new CAR-T-cell therapy at Hollings offers another shot at remission.

MUSC Hollings Cancer Center researchers have secured important funding for trials to reduce vaping among adolescents.

A multidisciplinary Hollings team is collaborating on a project to make CAR-T-cell therapy safer and more effective.

Robert Conley overcame the removal of multiple organs, including part of his stomach, to be ready to ride in LOWVELO 2021.

Dr. Besim Ogretmen and his research team found a new link between aging, metabolism and anti-cancer T-cell function.

Hollings researcher Dr. Jen Wang was awarded a $225,000 Young Investigator grant from the Melanoma Research Alliance.

Dr. Craig Lockhart shares his background and future vision for Hollings as he begins three clinical leadership roles at MUSC.

MUSC neurologists are the first to develop a preclinical brain cancer model using cutting-edge BrainPath technology.

Hollings researchers have discovered a more efficient way to enhance gene silencing for potential use in cancer drugs.